Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma

To date, PDAC remains the cancer having the worst prognosis with mortality rates constantly on the rise. Efficient cures are still absent, despite all attempts to understand the aggressive physiopathology underlying this disease. A major stumbling block is the outdated preclinical modeling strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Swayden, Mirna, Soubeyran, Philippe, Iovanna, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987422/
https://www.ncbi.nlm.nih.gov/pubmed/32038993
http://dx.doi.org/10.3389/fonc.2019.01443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987422/
https://www.ncbi.nlm.nih.gov/pubmed/32038993
http://dx.doi.org/10.3389/fonc.2019.01443

Ejemplares similares